Avandia Put to Test By FDA Committee
After years of controversy, the Food and Drug Administration is gearing up to decide the fate of popular diabetes drug, Avandia. An FDA advisory panel of experts will meet next week to weigh the evidence against Avandia and make a recommendation as to whether the GlaxoSmithKline drug poses cardiovascular risk to patients and should be pulled from the market. GlaxoSmithKline – Food and Drug …